[Biotransformation of 2-phenyl-4-/beta-dimethylamino-ethyl/-6-methyl-2,3-dihydro-1,4-benzoxazine-3-one ("AR 17 O48) a potential antirheumatic agent].
D000284:Administration, Oral; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000378:metabolism*; D001711:Biotransformation; D008297:Male; D010078:Oxazines / Q000008:administration & dosage / Q000378:metabolism*; D051381:Rats
D000893:Anti-Inflammatory Agents; D010078:Oxazines
Biotransformation von 2-Phenyl-4-[beta-dimethylaminoäthyl]-6-methyl-2.3-dihydro-1.4-benzoxazin-3-on ("AR 17 048"), einem potentiellen Antirheumaticum.